Author

Mark Rhoge

Observed name: M. Rhoge

Institutions: Brigham and Women's Hospital, Harvard University

Observed institutions: Brigham and Women's Hospital, Harvard University

OpenAlex ID: A5138989491

Unlocking Universal Treg Therapy for IRI and Transplantation via ICAM-1-Specific Antigen Receptors

2026 · S.K. Eskandari, N. Younis, et al. · American Journal of Transplantation

CD74 Controls Macrophage Plasticity and Allograft Fibrosis via the IFN-γ Receptor

2026 · H. Djebli, N. Al Rahy, et al. · American Journal of Transplantation

HLA-E-Restricted CD8 Tregs Represent a Promising Cell-Based Therapy Surpassing CD4 Tregs and CAR-Tregs Achieving Superior Allograft Survival

2026 · S. Al Chaar, H. Djebli, et al. · American Journal of Transplantation

CD74 is a Novel Obligate Coreceptor of the IFN-γ Receptor Critical for Allograft Rejection: From Mechanistic Discovery to Identifying Small Molecule Inhibitors with Machine Learning

2026 · N. Al Rahy, S.K. Eskandari, et al. · American Journal of Transplantation

NKG2A Checkpoint Restrains Qa-1/HLA-E-Restricted CD8 Tregs; Its Blockade Unleashes CD8 Tregs Function and Prevents Rejection

2026 · S. Al Chaar, H. Djebli, et al. · American Journal of Transplantation

Nanodisc‐Based Platform for HLA Antibody Identification

2026 · Mostafa T Mohammed, Wenpeng Liu, et al. · Advanced Functional Materials

Regulatory T Cells and the Evolution of Immune Tolerance: From Thymic Selection to CAR-Treg Therapies

2025 · Mark Rhoge, Nour Younis, et al. · Discovery Medicine

Works count: 7

Citation count:

H-index:

I10-index: